Michael Kassiou is an Associate Professor in the School of Chemistry and Medical Radiation Sciences at the University of Sydney and Head of the Drug Discovery Research Unit at the Brain and Mind Research Institute. A/Professor Kassiou has been responsible for fundamental contributions in a number of areas which encompass the interface between chemistry and biology. His group is primarily concerned with the understanding of drug-protein and drug-binding site interactions in order to obtain structure-activity relationships of bioactive CNS molecules. This allows the rationale design of more efficacious treatments for diseases of the brain. [More...]

Michael Kassiou is an Associate Professor in the School of Chemistry and Medical Radiation Sciences at the University of Sydney and Head of the Drug Discovery Research Unit at the Brain and Mind Research Institute. A/Professor Kassiou has been responsible for fundamental contributions in a number of areas which encompass the interface between chemistry and biology. His group is primarily concerned with the understanding of drug-protein and drug-binding site interactions in order to obtain structure-activity relationships of bioactive CNS molecules. This allows the rationale design of more efficacious treatments for diseases of the brain.

He is the author of over 90 scientific research papers, reviews and book chapters, and is a co-inventor of 7 patents. He is a thematic editor for Current Pharmaceutical Design and serves on the editorial advisory board of Letters in Drug Design and Discovery, Medicinal Chemistry, Current Medicinal Chemistry, Recent Patent Reviews on CNS Drug Discovery, Current Radiopharmaceuticals, The Open Medicinal Chemistry Journal, The Open Organic Chemistry Journal, Current Bioactive Compounds, Journal of Labelled Compounds and Radiopharmaceuticals and Journal of Biomedicine and Biotechnology. He is a management committee member for Chemistry in Australia and a fellow of the Royal Australian Chemical Institute. [Hide detail]